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S U M M A R Y
Objective: There are limited sources describing the global burden of emerging diseases. We reviewed the
Crimean-Congo hemorrhagic fever virus (CCHFV) infections reported by ProMED and assessed the
reliability of the data retrieved compared to published reports. We evaluated the effectiveness of
ProMED as a source of epidemiological data by focusing on CCHFV infections.
Methods: Using the keywords ‘‘Crimean Congo hemorrhagic fever’’ and ‘‘Crimean Congo’’ in the ProMED
search engine, we reviewed all the information about the news and harvested data using a structured
form, including year, country, gender, occupation, the number of infected individuals, and the number of
fatal cases.
Results: We identiﬁed 383 entries reported between January 1998 and October 2013. A total 3426
infected cases were reported, with 451 fatal cases, giving an overall case fatality rate (CFR) of 13%. Out of
144 cases for which the gender was reported, 97 (67%) were male. Most of the cases were reported from
Turkey, followed by Russia, Iran, Pakistan, and Afghanistan.
Conclusions: Case reporting systems such as ProMED are useful to gather information and synthesize
knowledge on the emerging infections. Although certain areas need to be improved, ProMED provided
good information about Crimean-Congo hemorrhagic fever.
 2014 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a fatal viral infection
described in Africa, Asia, Southeastern Europe, and the Middle East.1
The CCHF virus (CCHFV) belongs to the genus Nairovirus of the family
Bunyaviridae, and causes severe disease in humans, with a reported
case fatality rate (CFR) of 3–30%.1 Humans can become infected
through the bites of ticks, by contact with patient body ﬂuids, or by
contact with blood or tissues from viremic livestock. Some
occupational groups, including healthcare workers (HCWs), are at
risk of CCHF infection. Healthcare-related CCHF infections have been
reported in Pakistan,2–5 the United Arab Emirates,6 South Africa,7
Iran,8 India,9 Tajikistan,10 and Turkey.11
The global burden of disease needs to be described, but there are
limited sources from which to retrieve data regarding the disease.
ProMED (The Program for Monitoring Emerging Diseases) is an
internet-based reporting system for emerging infectious or toxin-
mediated diseases threatening human beings.12,13 It was founded in
1994 and is currently a program of the International Society for* Corresponding author.
E-mail addresses: oergonul@ku.edu.tr, oergonul@gmail.com (O. Ergonul).
http://dx.doi.org/10.1016/j.ijid.2014.04.005
1201-9712/ 2014 Published by Elsevier Ltd on behalf of International Society for Infect
creativecommons.org/licenses/by-nc-nd/3.0/).Infectious Diseases.13,14 Its mission is to serve global health by the
immediate dissemination of information, which may lead to early
preventive measures, prevent epidemiologic outbreaks, and provide
more accurate disease control. Its source of information is media
reports, ofﬁcial reports, online summaries, local observers, and
others.15 The reports are reviewed and edited by expert moderators
in the ﬁeld of infectious diseases and are then submitted to the mail
server and published on the website. Being a non-proﬁt, non-
governmental system, it is free from governmental constraints.13,14
It currently has over 60 000 subscribers in over 180 countries.
We reviewed the CCHFV infections reported by ProMED and
assessed the reliability of the data retrieved compared to published
reports. We thus evaluated the effectiveness of ProMED as an
epidemiological data source by focusing on CCHFV infections.
2. Methods
The keywords ‘‘Crimean Congo hemorrhagic fever’’ and ‘‘Crimean
Congo’’ were used in the ProMED search engine. We reviewed all the
information about the news and harvested data using a structured
form, including year, country, gender, occupation, the number of
infected individuals, and the number of fatal cases.ious Diseases. This is an open access article under the CC BY-NC-ND license (http://
Table 1
The number of infected and fatal CCHF cases reported to ProMED between 1998 and
2013
Country Infected
patients, n
Fatal
cases, n
CFR (%)
Turkey 1406 140 10
Russia 891 33 4
Iran 323 38 12
Pakistan 230 92 40
Afghanistan 61 16 26
Kazakhstan 54 21 39
Kosovo 47 11 23
India 42 25 60
Mauritania 35 6 17
Tajikistan 34 28 82
South Africa 17 5 29
Bulgaria 6 1 17
Greece 5 2 40
Iraq 2 2 100
Namibia 2 0 0
United Arab Emirates 5 2 40
Uganda 5 5 100
Georgia 1 0 0
Oman 1 1 100
Senegal 1 0 0
Zimbabwe 1 1 100
Total 3426 451 13
CCHF, Crimean-Congo hemorrhagic fever; CFR, case fatality rate.
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Three hundred and eighty-three entries reported between
January 1998 and October 2013 were identiﬁed. A total 3426
infected cases were reported, with 451 fatal cases, giving an overall
CFR of 13%. Out of 144 cases for which the gender was reported, 97
(67%) were male. The occupational status was reported for 96, of
whom 58 were farmers, 21 were HCWs, 12 were butchers, and ﬁve
were leather business workers.
The distribution of the infected and fatal cases by country is
presented in Table 1. Most of the cases were reported from Turkey,
followed by Russia, Iran, Pakistan, and Afghanistan (Table 1). The
lowest fatalities were reported from Russia (4%) and Turkey (10%).
4. Discussion
Global data tools are important and necessary to describe
emerging public health threats. ProMED was enthusiastically
started almost 20 years ago for the reporting of emerging diseases.
Using ProMED as a search tool, 451 fatal cases of CCHF infection
occurred among 3426 reported cases, giving a CFR of 13%. We
compared the results obtained from ProMED with the recent
published literature or the updated ofﬁcial reports from the
countries where CCHF incidences were reported to be highest.
In Turkey, the Turkish Ministry of Health reported 8047
conﬁrmed CCHF cases with 396 deaths occurring between 2002
and 2014, giving a CFR of 5%; we calculated a CFR of 10% from the
ProMED reports (Table 1). For Russia, we calculated a CFR of 3.7%
using the ProMED reports (Table 1), whereas Bente et al.16 reported
a CFR of 3.2% between the years 1999 and 2008 in Russia. For Iran,
the CFR was calculated as 11.8% during 1998–2013 from ProMED
reports. However, a recent study published in 2012 reported 126
deaths out of 870 conﬁrmed cases, giving a CFR of 17.8%.17 In
Kosovo, between 1995 and 2010, the CFR of CCHF was reported as
19%,18 and we calculated it as 23% from the ProMED reports. In
South Africa, the CFR was found to be to 29.4% according to ProMED
reports. However, Msimang et al. reported a CFR of 35%.19
HCWs are at occupational risk of CCHF infection by contact with
patient body ﬂuids.20,21 This uncommon transmission, occurring
for example by needle stick injury, can take place in the hospital
among HCWs, therefore infected patients should be managedFigure 1. Annual number of reported cases of CCHF by country—World Health Organizationcarefully and the administration of prophylactic therapy should be
considered if the HCWs are at risk of exposure.22 According to
ProMED reports, 21 HCWs were infected with CCHF, and none of
the entries reported prophylactic ribavirin administration to
HCWs. A recent report suggested ribavirin prophylaxis for HCWs
who are exposed to CCHFV infections.23
CFRs were found to be similar in the ProMED reports and
the published literature. The total number of cases reported to
ProMED reﬂects about one fourth to one half of the published or
reported cases. The distributions of cases reported by the World
Health Organization and by ProMED are shown in Figures 1 and 2.
There are some limitations to harvesting data from ProMED.
One of the most important limitations is reporting bias that could
be related to (1) the lack of availability of capable volunteer
reporters, (2) the presence of ofﬁcial pressure not to report in some
countries, and (3) change in risk perception. (http://www.who.int/csr/disease/crimean_congoHF/Global_CCHFRisk_20080918.png).
Figure 2. Total number of reported cases of CCHF by country, based on entries in ProMED between the years 1998 and 2013.
Table 2
Short template for individual cases
Date
Age
Gender
Profession
Country/state
Treatment received
Outcome
Comments
Table 3
Short template for massive alerts
Date
Country/state
Total number of patients
Number of female patients
Number of treated patients
Number of deaths among treated patients
Total number of deaths
Comments
Y. Ince et al. / International Journal of Infectious Diseases 26 (2014) 44–4646With regard to the ProMED reporting system, the use of a
structured template for alerts instead of narrating the episodes
would provide more clear and precise information. Different
structured report formats could be used at the case and population
levels. Information on prophylaxis, the duration of episodes, and
transmission routes would be useful. Such an arrangement could
standardize the information in the ProMED system and may
therefore provide more reliable data. The use of such templates
would also provide ProMED the opportunity to automatically
calculate annual incidence and fatality rates, producing concrete
epidemiological data. A user-friendly comment section may be
added in order to prevent discussions being made in the form of
alerts (Tables 2 and 3).
In conclusion, case reporting systems such as ProMED are useful
to gather information and synthesize knowledge about emerging
infections. Although certain areas need to be improved, ProMED
provided good information about Crimean-Congo hemorrhagic
fever.
Conﬂict of interest: There is no conﬂict of interest.
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